Domain Associates, a US venture capital firm investing in life sciences technologies, has promoted Nimesh Shah to partner.
Shah (pictured) joined Domain in 2006.
"Nimesh has been instrumental at Domain in driving opportunities in the rapidly evolving medical device space," says Brian Dovey, partner at Domain Associates. "He brings a depth of knowledge to and works closely with our entrepreneurs and management teams to build the next generation of great device companies."
"Working with entrepreneurs means that you are working with people who are passionate about what they do," says Shah. "It’s hard not to be equally infected with the same level of enthusiasm, especially to be able to do so in such a dynamic environment."
Shah is a co-founder and board member of Zyga Technology and is a board member of Benvenue Medical, Cotera, Miramar Labs, Sequent Medical, and Twelve (Foundry Newco VII). He also serves as a board observer at ReVision Optics and Tandem Diabetes Care. Shah is also involved with The Foundry, a medical devices incubator. He currently serves on the Dean’s Leadership Council for the UCSD School of Biological Sciences and as a board member for the San Diego Venture Group.
Prior to Domain, Shah was part of the investment team at the venture firm, Cutlass Capital, and a member of the medical device research team at Alex. Brown & Sons (now Deutsche Bank).
